Hope for this and many other diseases is fueled by a United Kingdom researcher who is trying to develop delivery systems that bypass these faulty cell membrane proteins to properly orchestrate the ...
Biotech Fluidics offers a range of non-invasive flowmeters for real-time, non-invasive monitoring of liquid flow.
CDMO partner Freudenberg Medical recently launched CleanAssure, an ISO Class 5 controlled cleanroom for sterile single-use assemblies. The cleaning and sterilisation service supports biopharmaceutical ...
A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...
Servier, an independent international pharmaceutical company governed by a foundation, and n-Lorem Foundation, a non-profit organisation established to provide experimental medicines to patients with ...
Waters Corporation has launched a the Xevo MRT P10 mass spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) system for high-throughput multiomics, bioanalysis and biopharmaceutical ...
Independent European studies presented at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 and Alzheimer’s & Parkinson’s Disease Conference (ADPD) 2026 confirmed that the HISCL p-Tau217 RUO and ...
As the oncology drug pipeline faces unprecedented target saturation, industrial R&D teams are actively seeking sophisticated molecular architectures that offer superior selectivity, accelerated ...
CCRM and CDMO subsidiary OmniaBio have partnered with Avectas to evaluate its automated, integrated, and scalable cell therapy manufacturing platform. The evaluation will explore how Avectas’ platform ...
Aignostics has formed a partnership with the Pancreatic Cancer Action Network (PanCAN) to generate and share spatial profiling readouts for one of the most comprehensive pancreatic cancer datasets ...
Innovative Molecules (IM), a clinical-stage biopharmaceutical company focused on herpesvirus-mediated diseases, has advanced its virology pipeline by adding a novel Epstein-Barr Virus (EBV) antiviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results